RE
$634.62
-4.26
(-0.67%)
As of May 26, 2026, 8:50 PM EDT
Regeneron Pharmaceuticals (REGN) is trading down at $634.62 (-0.67%) on NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
About Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.
Recent News (3)
-
Canaccord Cuts PT on Regeneron Pharmaceuticals (REGN), Cites a Disappointing Event Canaccord Cuts PT on Regeneron Pharmaceuticals (REGN), Cites a Disappointing Event
-
Abortion pills "just in case"? Planned Parenthood will offer them in two states In Washington state and Hawaii, residents can now get mifepristone and misoprostol from Planned Parenthood to keep in their cabinets in case they need to end a pregnancy at a later time.
-
Jim Cramer on Regeneron: “There Could Be Some More Downgrades” Jim Cramer on Regeneron: “There Could Be Some More Downgrades”